Atemwegsinfektionen bei immunsupprimierten Personen

Pulmonary infections in immunocompromised patients remain a diagnostic and therapeutic challenge.New methods for the early detection of fungal and viral diseases might allow an immediate and specific therapy, thereby lowering the high mortality associated with such infections.The development of new...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockschläder, M., Montemurro, M., Kiefer, T., Dölken, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2003
Materias:
Leitthema: Atemwegserkrankungen bei Kindern und Erwachsenen
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095897/
http://dx.doi.org/10.1007/s00103-002-0536-7
_version_ 1783510707971555328
author Stockschläder, M.
Montemurro, M.
Kiefer, T.
Dölken, G.
author_facet Stockschläder, M.
Montemurro, M.
Kiefer, T.
Dölken, G.
author_sort Stockschläder, M.
collection PubMed
description Pulmonary infections in immunocompromised patients remain a diagnostic and therapeutic challenge.New methods for the early detection of fungal and viral diseases might allow an immediate and specific therapy, thereby lowering the high mortality associated with such infections.The development of new drugs will hopefully lead to more effective treatment while decreasing the incidence of adverse effects. Interdisciplinary team work between internal medicine, radiology, surgery, microbiology, and virology is essential for the successful management of these patients.
format Online
Article
Text
id pubmed-7095897
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70958972020-03-26 Atemwegsinfektionen bei immunsupprimierten Personen Stockschläder, M. Montemurro, M. Kiefer, T. Dölken, G. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Leitthema: Atemwegserkrankungen bei Kindern und Erwachsenen Pulmonary infections in immunocompromised patients remain a diagnostic and therapeutic challenge.New methods for the early detection of fungal and viral diseases might allow an immediate and specific therapy, thereby lowering the high mortality associated with such infections.The development of new drugs will hopefully lead to more effective treatment while decreasing the incidence of adverse effects. Interdisciplinary team work between internal medicine, radiology, surgery, microbiology, and virology is essential for the successful management of these patients. Springer-Verlag 2003 /pmc/articles/PMC7095897/ http://dx.doi.org/10.1007/s00103-002-0536-7 Text en © Springer-Verlag Berlin Heidelberg 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema: Atemwegserkrankungen bei Kindern und Erwachsenen
Stockschläder, M.
Montemurro, M.
Kiefer, T.
Dölken, G.
Atemwegsinfektionen bei immunsupprimierten Personen
title Atemwegsinfektionen bei immunsupprimierten Personen
title_full Atemwegsinfektionen bei immunsupprimierten Personen
title_fullStr Atemwegsinfektionen bei immunsupprimierten Personen
title_full_unstemmed Atemwegsinfektionen bei immunsupprimierten Personen
title_short Atemwegsinfektionen bei immunsupprimierten Personen
title_sort atemwegsinfektionen bei immunsupprimierten personen
topic Leitthema: Atemwegserkrankungen bei Kindern und Erwachsenen
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095897/
http://dx.doi.org/10.1007/s00103-002-0536-7
work_keys_str_mv AT stockschladerm atemwegsinfektionenbeiimmunsupprimiertenpersonen
AT montemurrom atemwegsinfektionenbeiimmunsupprimiertenpersonen
AT kiefert atemwegsinfektionenbeiimmunsupprimiertenpersonen
AT dolkeng atemwegsinfektionenbeiimmunsupprimiertenpersonen

Ejemplares similares